Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR ‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61
ConclusionsThe risk of HHF varies across BMI categories for any given range of circulating NT-proBNP. These findings showcase the importance of considering BMI when applying NT-proBNP for HF risk stratification, particularly for patients with low-level elevations in NT-proBNP (125-<450 pg/mL) where there appears to be a clinically meaningful absolute and relative risk gradient.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Siddharth M. Patel,
David A. Morrow,
Andrea Bellavia,
David D. Berg,
Deepak L. Bhatt,
Petr Jarolim,
Lawrence A. Leiter,
Darren K. McGuire,
Itamar Raz,
P. Gabriel Steg,
John P. H. Wilding,
Marc S. Sabatine,
Stephen D. Wiviott,
Eugene Braunwald Tags: Research Article Source Type: research
More News: Cardiology | Clinical Trials | Dapagliflozin | Eating Disorders & Weight Management | Forxiga | Heart | Heart Failure | Legislation | Obesity